Unichem Laboratories

685.95
-8.55
(-1.23%)
Market Cap
4,829.48 Cr
EPS
-10.01
PE Ratio
58.11
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
937.95
52 Week Low
492.70
PB Ratio
2.05
Debt to Equity
0.12
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
negative
Unichem Laboratories to Close UK Manufacturing Facility5 days ago
Unichem Laboratories has announced the closure of its manufacturing facility in the United Kingdom. The company has described the facility as 'niche', suggesting it may not be a core part of their operations. This decision likely stems from strategic considerations to optimize their manufacturing footprint or reduce costs.
neutral
Unichem Laboratories to Transfer 100% Stake in Unichem Ireland to IPCA Laboratories5 days ago
Unichem Laboratories has announced its decision to transfer its entire 100% stake in its subsidiary, Unichem Ireland, to IPCA Laboratories. This move represents a significant corporate action involving the divestment of a foreign subsidiary to another pharmaceutical company.
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,713.65
#1 4,11,162.04
34.52
#1 49,887.20
12.06
#1 9,648
13.77
50.47
5,666.00
1,50,414.50
71.26
8,184.00
0.89
1,600
#1 64.53
46.20
1,452.35
1,17,293.96
23.38
26,520.70
14.17
4,155
47.38
45.27
3,207.10
1,08,542.84
57.83
10,785.70
11.59
1,656
13.54
55.87
2,421.90
99,922.39
49.65
10,615.60
19.57
1,942
-16.38
55.89
1,150.00
95,962.37
#1 17.90
28,905.40
12.36
5,578
1.69
45.11
2,009.70
91,751.03
31.14
20,141.50
#1 19.94
1,936
38.82
47.61
891.15
89,670.54
19.47
19,831.50
13.82
3,831
29.92
44.76
1,157.85
67,248.12
18.70
29,559.20
17.55
3,169
-10.04
52.27
29,540.90
62,772.35
48.26
6,097.20
10.80
1,201
16.01
44.78
Growth Rate
Revenue Growth
25.70 %
Net Income Growth
-65.13 %
Cash Flow Change
119.61 %
ROE
-64.10 %
ROCE
-74.64 %
EBITDA Margin (Avg.)
-1,588.24 %

Quarterly Financial Results

Quarterly Financials
Mar 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
216
278
260
293
331
402
300
296
300
303
334
328
342
282
314
293
326
384
318
338
319
407
432
421
545
438
450
516
547
Expenses
192
260
276
318
325
350
294
295
292
277
305
288
296
255
300
284
313
302
311
352
345
419
395
407
435
532
403
452
448
EBITDA
24
18
-16
-25
5
52
6
1
8
26
29
40
46
27
14
9
13
83
7
-14
-26
-12
37
14
110
-94
47
64
99
Operating Profit %
-3 %
-10 %
-14 %
-22 %
-7 %
7 %
-7 %
-10 %
-6 %
5 %
4 %
9 %
9 %
7 %
-1 %
2 %
-0 %
19 %
-0 %
-7 %
-14 %
-4 %
7 %
2 %
7 %
-23 %
10 %
11 %
16 %
Depreciation
11
14
14
16
18
19
18
21
20
23
21
21
21
22
22
22
23
23
25
28
31
30
29
30
32
27
28
32
31
Interest
0
3
1
1
1
4
1
2
2
2
1
1
1
2
1
2
1
2
3
5
4
6
6
7
6
5
4
5
7
Profit Before Tax
13
2
-31
-43
-14
29
-14
-22
-13
0
7
18
24
3
-9
-16
-11
58
-21
-47
-61
-47
2
-22
73
-126
15
27
62
Tax
-16
4
-10
-2
-14
-9
-8
1
1
18
5
9
-0
3
2
-3
3
-14
3
23
3
-3
3
3
0
3
6
3
4
Net Profit
29
-2
-21
-41
-0
38
-6
-22
-15
-17
2
9
24
-0
-12
-13
-14
72
-23
-71
-64
-44
-1
-25
73
-129
9
25
58
EPS in ₹
3.19
0.00
-2.91
-5.83
-0.04
4.51
-0.88
-3.15
-2.07
-2.44
0.35
1.24
3.35
-0.06
-1.63
-1.82
-2.01
10.15
-3.32
-10.04
-9.08
-6.28
-0.09
-3.48
10.39
-18.37
1.31
3.50
8.22

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,169
1,284
1,527
3,194
3,150
3,145
3,126
3,319
3,193
3,169
Fixed Assets
416
403
491
578
810
870
884
990
1,257
1,196
Current Assets
564
600
749
2,337
2,038
1,687
1,377
1,648
1,589
1,694
Capital Work in Progress
123
237
250
238
92
331
568
494
148
123
Investments
35
14
14
901
926
550
392
264
2
1
Other Assets
595
630
772
1,476
1,321
1,395
1,282
1,571
1,787
1,849
Total Liabilities
1,169
1,284
1,527
3,194
3,150
3,145
3,126
3,319
3,193
3,169
Current Liabilities
212
243
393
464
503
567
506
552
640
708
Non Current Liabilities
89
86
70
50
27
47
63
148
118
99
Total Equity
868
954
1,064
2,680
2,620
2,531
2,557
2,618
2,435
2,362
Reserve & Surplus
849
936
1,045
2,666
2,606
2,517
2,543
2,604
2,421
2,348
Share Capital
18
18
18
14
14
14
14
14
14
14

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-25
-7
-1
655
-616
-78
-154
32
75
-33
Investing Activities
-52
-85
-128
1,648
-286
-36
-66
100
241
57
Operating Activities
78
112
68
-112
-328
20
33
-260
-85
17
Financing Activities
-51
-33
59
-881
-2
-62
-121
191
-81
-106

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
70.21 %
70.22 %
70.22 %
70.22 %
70.22 %
70.22 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.83 %
0.00 %
0.90 %
0.89 %
0.94 %
1.06 %
DIIs
8.49 %
8.49 %
8.49 %
8.49 %
8.49 %
8.38 %
7.55 %
8.20 %
8.16 %
7.39 %
10.32 %
9.29 %
11.27 %
11.58 %
11.67 %
11.63 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.48 %
30.39 %
30.50 %
30.27 %
29.81 %
29.95 %
30.17 %
30.99 %
30.91 %
26.86 %
15.80 %
15.63 %
15.12 %
14.80 %
14.58 %
14.47 %
Others
10.09 %
10.19 %
10.08 %
10.31 %
10.77 %
10.73 %
11.34 %
9.87 %
9.99 %
14.81 %
2.84 %
4.85 %
2.49 %
2.50 %
2.60 %
2.62 %
No of Share Holders
0
33,734
34,258
33,892
35,313
33,557
32,666
29,573
29,418
26,642
21,584
20,877
21,171
20,621
20,374
21,472

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 3 5 4 4 4 4 4 0.00 0.00
Dividend Yield (%) 0.00 1.05 2.57 2.57 1.29 1.54 1.39 0.81 0.00 0.00

Corporate Action

Announcements

Board Meeting Outcome for Outcome Of Board Meeting5 days ago
Closure of Trading Window8 days ago
Announcement Under Regulation 30Mar 20, 2025
USFDA Approval For CompanyS Pithampur API FacilityMar 01, 2025
Board Meeting Outcome for Outcome Of Board MeetingMar 01, 2025
Announcement under Regulation 30 (LODR)-Credit RatingFeb 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2025
Integrated Filing (Financial)Feb 06, 2025
Financial ResultsFeb 06, 2025
Included Mr. Utkarsh Patil Chief Manufacturing Officer - Formulations As A Senior Management Personnel Under SEBI LODR Regulations With Effect From 6Th February 2025Feb 06, 2025
Board Meeting Outcome for Unaudited Financial Results (Consolidated & Standalone) For The Quarter And Nine-Months Ended 31St December 2024Feb 06, 2025
Announcement Under Regulation 30(LODR) - GST (Goods &Services Tax)Jan 27, 2025
Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Jan 24, 2025
Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024.Jan 14, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Intimation By Registrar & Transfer Agent (RTA)Jan 03, 2025
Resignation Of Senior Managerial Personnel.Dec 17, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Amendment In Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive InformationNov 13, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 13, 2024
Board Meeting Outcome for Unaudited Financial Statements (Consolidated & Standalone) For The Second Quarter And Half Year Ended 30Th September 2024Nov 13, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 10, 2024
Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended September 30, 2024.Oct 25, 2024
Reply Letter On A Significant Increase In The Volume.Oct 23, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 11, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 04, 2024
Board Meeting Outcome for Outcome Of Board MeetingSep 30, 2024
Closure of Trading WindowSep 23, 2024
Board Meeting Intimation for Integration And Consolidation Of The Generics FormulationsBusiness In The US Market.Sep 23, 2024
Intimation Under Regulation 30 Of SEBI LODRSep 10, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2024
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressSep 03, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 23, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportAug 08, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 08, 2024
Change In Key Managerial Personnel For Determining And Disclosure Of Material EventsAug 08, 2024
Board Meeting Outcome for Outcome Of Board MeetingAug 08, 2024
Outcome Of Board MeetingAug 08, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 05, 2024
Board Meeting Intimation for Financial ResultsJul 26, 2024
USFDA Inspection At Goa Formulation FacilityJul 15, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 12, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 11, 2024
Notice Of The 61St Annual General MeetingJul 11, 2024
Business Responsibility and Sustainability Reporting (BRSR)Jul 11, 2024
Reg. 34 (1) Annual Report.Jul 11, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 01, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJul 01, 2024
Shareholder Meeting - AGM On August 8, 2024Jun 28, 2024

Technical Indicators

RSI(14)
Neutral
51.54
ATR(14)
Less Volatile
29.84
STOCH(9,6)
Neutral
66.93
STOCH RSI(14)
Neutral
71.36
MACD(12,26)
Bullish
4.48
ADX(14)
Weak Trend
18.36
UO(9)
Bearish
45.82
ROC(12)
Uptrend And Accelerating
7.38
WillR(14)
Neutral
-38.06